ArticleThe oncologist2025

Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.

Cindy Y Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.